Drug treatment during pregnancy and isolated orofacial clefts in Hungary

Cleft Palate-Craniofacial Journal

Volumn 44, Issue 2, 2007, Pages 194-202

  Puhó, Erzsébet H ^a   Szunyogh, Melinda ^b   Métneki, Júlia ^b   Czeizel, Andrew E ^a,c  

^a FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

^b National Center for Healthcare Audit and Improvement   (Hungary)

^c NONE   (Hungary)

Author keywords

Amoxicillin; Carbamazepine; Case control studies; Cleft lip; Cleft lip and palate; Oxprenolol; Oxytetracycline; Phenytoin; Posterior cleft palate; Pregnancy; Thiethylperazine

Indexed keywords

AMOXICILLIN; CARBAMAZEPINE; OXPRENOLOL; OXYTETRACYCLINE; PHENYTOIN; THIETHYLPERAZINE;

ARTICLE; CLEFT FACE; CLEFT LIP PALATE; CONTROLLED STUDY; FEMALE; HUMAN; HUNGARY; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PREGNANCY; PRIORITY JOURNAL; PROGENY; PROSPECTIVE STUDY; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SELF REPORT;

ABNORMALITIES, DRUG-INDUCED; ADRENERGIC BETA-ANTAGONISTS; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTICONVULSANTS; CARBAMAZEPINE; CASE-CONTROL STUDIES; CLEFT LIP; CLEFT PALATE; DOPAMINE ANTAGONISTS; DRUG THERAPY; FEMALE; HUMANS; HUNGARY; OXPRENOLOL; OXYTETRACYCLINE; PHENYTOIN; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY TRIMESTERS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; THIETHYLPERAZINE;

EID: 33947204492     PISSN: 10556656     EISSN: None     Source Type: Journal    
DOI: 10.1597/05-208.1     Document Type: Article

References (41)

1. Baden E. Environmental pathology of teeth. In: Gorlin RJ, Goldman MM, eds. Oral Pathology. St Louis: Mosby; 1970:190.
2. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 7th ed. Philadelphia: Lippincott Williams and Wilkins; 2005:1223-1224.
3. Cavenee MR, Farris JR, Spalding TR, Barnes DL, Castaneda YS, Wendel GD Jr. Treatment of gonorrhoea in pregnancy. Obstet Gynecol. 1993;81:31-38.
4. Cohen MM. Syndromes with orofacial clefting. In: Wyszynski DF, ed. Cleft Lip and Palate: From Origin to Treatment. New York: Oxford University Press; 2002:53-65.
5. Cohlan SQ. Tetracycline staining of teeth. Teratology. 1977;15:127-130.
6. Czeizel AE. The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology. 1997;55:299-305.
7. Czeizel AE, Bod M., Halász P. Evaluation of anticonvulsant drugs during pregnancy in a population-based Hungarian study. Eur J Epidemiol. 1992;8:122-127.
8. Czeizel AE, Ers E, Rockenbauer M, Sorensen HT, Olsen J. Short-term oral diazepam treatment during pregnancy. Clin Drug Invest. 2003a;23:451-462.
9. Czeizel AE, Hirschberg I. Orofacial clefts in Hungary. Folia Phoniatr Logop. 1997;49:111-116.
10. Czeizel AE, Huiskes NA. A case-control study to evaluate the risk of congenital anomalies as a result of allylestrenol therapy during pregnancy. Clin Therap. 1988;10:725-739.
11. Czeizel AE, Petik D, Puhó E. Smoking and alcohol drinking during pregnancy. The reliability of terrispective maternal self-reported information. Cent Eur J Publ Health. 2004a;12:179-183.
12. Czeizel AE, Petik D, Vargha P. Validation studies of drug exposures in pregnant women. Pharmacoepid Drug Safety. 2003b;12:409-416.
13. Czeizel AE, Puhó E, Acs N, Bánhidy F. Inverse association between severe nausea and vomiting in pregnancy and some congenital abnormalities. Am J Med Genet. 2006;140A:453-462.
14. Czeizel AE, Rockenbauer M. A population-based case-control teratologic study of oral oxytetracycline treatment during pregnancy. Eur J Obstet Gynec Reprod Biol. 2000;88:27-33.
15. Czeizel AE, Rockenbauer M, Siffel CS, Varga E. Description and mission evaluation of the Hungarian case-control surveillance of congenital abnormalities. Teratology. 2001;63:176-185.
16. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen I. A population-based case-control study of oral chlordiazepoxide use during pregnancy and risk of congenital abnormalities. Neurotox Terat. 2004b;26:293-598.
17. Czeizel AE, Telegdi L, Tusnády G. Multiple Congenital Abnormalities. Budapest: Akadémiai Kiadó; 1988.
18. Czeizel AE, Timár L, Sâközi A. Dose-dependent effect of folic acid on the prevention of orofacial cleft. Pediatrics. 1999;104:e66. 1-6.
19. Czeizel AE, Tusnády G. An epidemiological study of cleft lip with or without cleft palate and posterior cleft palate in Hungary. Hum Hered. 1971;21:17-38.
20. Czeizel AE, Vargha P. Case-control study of teratogenic potential of thiethylperazine, an antiemetic drug. Brit J Obstet Gynaec. 2003;110:497-499.
21. Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Is carbamazepine teratogenic? A prospective controlled study of 210 pregnancies. Neurology. 2001;57: 321-324.
22. Durner M, Greenberg DA, Delgado-Escueta V. Is there a genetic relationship between epilepsy and birth defects. Neurology. 1992;42:63-67.
23. Fogh-Anderson P. Inheritance of harelip and cleft palate. Copenhagen: Muskgaard; 1942.
24. Gallery EDM. Hypertension in pregnant women. Med J Aust. 1985;143:23-27.
25. Hanson JW, Smith DW. The fetal hydantoin syndrome. J Pediatr. 1975;87:285-290.
26. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Littleton, MA: Publishing Sciences Group; 1977:297-313.
27. Holmes LB, Harvey EA, Coull BA, Huntington KB, Khoshbin S, Hayes AM, Ryan LM. The teratogenicity of anticonvulsant drugs. N Engl J Med. 2001; 344:1132-1138.
28. Kaneko S, Otani K, Fukushima Y, Ogawa Y, Nomura Y, Ono T, Nakane Y, Teranishi T, Goto M. Teratogenicity of antiepileptic drugs: Analysis of possible risk factors. Epilepsia. 1988;4:459-467.
29. Meadow SR. Congenital abnormalities and anticonvulsants. Proc R Soc Med. 1970;63:48-49.
30. Métneki J, Puhó E, Czeizel AE. Maternal diseases and isolated orofacial clefts in Hungary. Birth Defects Research. Part A Clin Mol Teratol. 2005;73:617-623.
31. Monson RR, Rosenberg L, Hartz SC, Shapiro S, Heinonen OP, Slone D. Diphenyl hydantoin and selected congenital malformations. N Engl J Med. 1973;289:1049-1052.
32. Mossey PA, Little J. Epidemiology of oral clefts: An international perspective. In: Wyszynski DF, ed. Cleft Lip and Palate: From Origin to Treatment. New York: Oxford University Press; 2002:127-158.
33. Puhó E, Métneki J, Czeizel AE. Maternal employment status and isolated orofacial clefts in Hungary. Cent Eur J Publ Health. 2005;13:144-148.
34. Rockenbauer M, Olsen I, Czeizel AE, Pedersen L, Sprensen HAT, EuroMAP Group. Recall bias in a case-control study on the use of medicine during pregnancy. Epidemiology. 2001;12:461-466.
35. Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med. 1991;324:674-677.
36. Shaw GM, Croen LA, Curry CJ. Isolated oral cleft malformations: associations with maternal and infant characteristics in a California population. Teratology. 1991;43:225-228.
37. Szabo K, Brent RL. Species differences in experimental teratogenesis by tranquillising agents. Lancet. 1974;1:565.
38. Tolarova MM, Cervenka J. Classification and birth prevalence of orofacial clefts. Am J Med Genet. 1998;75:126-137.
39. Vieira AR, Orioli IM. Birth order and oral clefts: a meta analysis. Teratology. 2002;66:209-216.
40. Zeiger JS, Beaty TH. Gene-environment interaction and risk to oral clefts. In: Wyszynski DF, ed. Cleft Lip and Palate: From Origin to Treatment. New York: Oxford University Press; 2002a:283-289.
41. Zeiger JS, Beaty TH. Is there a relationship between risk factor for oral clefts? Teratology. 2002b;66:205-208.